- A new study reports that the incidence rates of most cancer types were lower in Black, Asian, and other
minoritizedgroups than their white counterparts in England.
- The incidence rates of certain cancer types, such as Hodgkin’s lymphoma, thyroid, and several gastrointestinal cancers, were higher in Asian and Black people.
- Lifestyle and other external risk factors likely drive the differences in cancer incidence rates among racial and ethnic groups.
- Understanding these underlying risk factors is necessary to inform public health measures and mitigate the differences in cancer incidence rates among racial groups.
A recent study published in the
The study found that the incidence rates of most cancer types, including skin melanoma and smoking-related cancers, were lower in Black, Asian, and other non-white people than in the white population. However, the incidence rates of certain cancer types, such as gastrointestinal cancers, thyroid cancer, and Hodgkin’s lymphoma, were higher in non-white racial groups.
The researchers noted that differences in exposure to risk factors, such as smoking and obesity, and access to or use of healthcare services, rather than genetic factors, were likely to account for most of the differences in cancer incidence rates among racial groups.
The results of this study highlight the importance of future studies to understand the factors underlying these differences. These studies could inform interventions to mitigate these risk factors, enhance access to healthcare services, and improve patient outcomes.
The study’s lead author Dr. Christine Delon, a research analyst at Cancer Research UK, says: “It’s really important to understand what the evidence is and where there are inequalities in cancer incidence to inform efforts in risk factor prevention and cancer service planning and delivery.”
Since then, more reliable data has become available, with considerable improvements in the completeness of data in healthcare records.
Dr. Delon said, “[Race and] ethnicity recording in cancer data at that time was quite incomplete. Around a quarter of cancer cases didn’t even have an ethnic group recorded. Data quality has improved now, and the composition and risk factor prevalence of England’s minority [race and] ethnic populations may have also changed over the past decade, so new information has been sorely needed.”
To address the shortcomings of these previous studies, the researchers obtained data from the National Cancer Registration and Analysis Service on cancer cases in England between 2013–2017. They calculated the incidence rates for different
The incidence rate for all cancer types considered together was higher in white than non-white people. Black males were an exception to this trend, with the cancer incidence rate in Black males being 14% higher than white males.
Moreover, the incidence rate of prostate cancer in Black males was 2.1 times higher than that in white males. The higher prostate cancer rates in Black individuals were largely responsible for the overall disparity in cancer incidence rates in these groups.
For specific cancer types, the incidence rates for most cancer sites in the Black, Asian, and Mixed or Multiple racial groups were either lower than or similar to the white racial group. The incidence rates of skin melanoma and cancers associated with smoking, such as lung and bladder cancers, were higher among white people than non-white people.
The lower prevalence of smoking in a significant subset of individuals in the Asian and Black communities could explain these results. Similarly, lower prevalence of obesity in these subsets — except in certain subgroups, such as Black Caribbean individuals, Black African women, and Pakistani women — may also account for the lower rates of breast, bowel, and uterine cancers.
However, the incidence rates of certain cancer types were higher in non-white people. The rates of Hodgkin lymphoma, thyroid cancer, and certain gastrointestinal cancers (liver and gallbladder) were higher in both Black and Asian people than in white people.
The Black racial group also had higher incidence rates of myeloma, uterine, and other gastrointestinal cancers (stomach, pancreatic) than its white counterpart.
Notably, the rates of myeloma were nearly three times higher among Black people than white people.
The prevalence of
The authors note that more research is needed to understand the factors underlying these differences in cancer incidence rates along racial lines. Such studies can inform interventions to mitigate these disparities.
Dr. Ruth Jack, a senior research fellow at the University of Nottingham, told Medical News Today, “[This study provides] updated information about cancer incidence in different [racial] groups in England. The recent improved collection of [race and] ethnicity information for people diagnosed with cancer has made this possible, and hopefully, further improvements will enable similar analyses to be done for more specific [racial and] ethnic groups.”
“Although some cancers may be less common in particular [racial and] ethnic groups, it is still important to recognize cancer as a possible diagnosis for people presenting with relevant symptoms, whatever their [race or ethnicity]. Diagnosing cancer as early as possible leads to better outcomes and improved trust in the healthcare profession.”
Although the incidence rates for most cancer types were lower in non-white racial and ethnic groups than among white people, individuals from non-white racial groups are more likely to receive a cancer diagnosis at more advanced stages than their white counterparts, the authors note.
Moreover, the authors propose that non-white people may have a lower awareness of cancer risk factors and symptoms.
This highlights the importance of measures to increase awareness of symptoms and risk factors and improve access to cancer screening among
Crucially, researchers are less likely to include a diverse sample of participants in
People within these groups who have cancer also report lower levels of satisfaction with the quality of medical care provided. Thus, public health measures are also needed to improve patient outcomes and experience.